Of the 11 candidate susceptibility regions, two regions were consistently associated with glioma risk across multiple studies and methods, 16p13.3 an intronic region of the RBFOX1 gene, and 1p36.21 containing the genes PDPN and PRDM2. The gene discussed is PDPN; the disease is central nervous system cancer.